Pharmaceuticals

Precision Medicine Market Forecast Showing Industry Progress And Growth Trends

May 4, 2026May 4, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

From Its 2026 Market Size, What Value Is The Precision Medicine Market Projected To Reach By 2030?

The precision medicine market has experienced robust expansion in recent years. This market is set to increase from $87.91 billion in 2025 to $96.27 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 9.5%. The historical growth trajectory is largely a result of breakthroughs in genomic research, the reduced expenses of gene sequencing, a rise in the incidence of cancer and genetic disorders, increased expenditure in biopharmaceutical research and development, and the regulatory clearances for targeted treatments.

The precision medicine market is anticipated to experience robust expansion in the coming years. Its valuation is projected to reach $137.69 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.4%. This projected growth during the forecast period is fueled by several factors, including the wider adoption of next-generation sequencing, a growing need for customized treatment strategies, the increasing application of AI in drug discovery, higher investments in precision diagnostics, and the incorporation of digital health platforms. Key trends anticipated over the forecast period encompass a surge in the uptake of companion diagnostics, a move towards tailored oncology treatments, the merging of multi-omics data for clinical choices, the broader application of precision medicine for rare and genetic conditions, and enhanced partnerships between pharmaceutical and diagnostic companies.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=5301&type=smp

Which Important Drivers Are Guiding The Precision Medicine Market Growth?

The increasing incidence of cancer is expected to accelerate the expansion of the precision medicine market. Cancer is recognized as a leading cause of death globally, with approximately one in five individuals experiencing a cancer diagnosis during their lifetime. Precision medicine, particularly in the context of cancer, involves analyzing the DNA of tumors to pinpoint mutations or other genetic anomalies that contribute to the disease. This approach enables physicians to select a treatment for a specific patient’s cancer that is optimally matched to, or targets, the detected alterations in the tumor DNA. For instance, in February 2024, the World Health Organization, a Switzerland-based specialized agency dedicated to international public health, projected that by 2050, over 35 million new cancer cases would emerge, representing a 77% increase from the estimated 20 million cases in 2022. Thus, the rising prevalence of cancer is a key factor driving the growth of the precision medicine market.

How Are Different Segments Classified In The Precision Medicine Market Segment Analysis?

The precision medicine market covered in this report is segmented –

1) By Technology: Big Data Analytics, Bioinformatics, Gene Sequencing, Drug Discovery, Companion Diagnostics, Other Technology

2) By Application: Oncology, Respiratory Diseases, Central Nervous System Disorders, Immunology, Genetic Diseases, Other Applications.

3) By End-Use: Pharmaceutical Companies, Diagnostic Companies, Healthcare And IT Firms, Others

Subsegments:

1) By Big Data Analytics: Predictive Analytics, Prescriptive Analytics, Data Mining

2) By Bioinformatics: Genomic Data Analysis, Proteomics Data Analysis, Metabolomics Data Analysis

3) By Gene Sequencing: Next-Generation Sequencing (NGS), Sanger Sequencing, Whole Genome Sequencing

4) By Drug Discovery: Target Identification And Validation, Lead Compound Discovery, Preclinical And Clinical Trials

5) By Companion Diagnostics: Biomarker Testing, Genomic Profiling, Companion Diagnostic Tests

6) By Other Technology: Personalized Treatment Plans, Telemedicine And Digital Health Solutions, Wearable Health Technology

Which Trends Are Influencing Demand In The Precision Medicine Market?

Major companies in the precision medicine market are concentrating on innovations such as data ingestion, which facilitates accessing public datasets through Google Cloud’s Analytics Hub. Data ingestion refers to the process of collecting and importing data from various sources into a storage system or a data processing platform. For example, in May 2023, Google Cloud, a US-based software development company, introduced two pioneering AI-powered solutions aimed at improving drug discovery and precision medicine. These new AI solutions are helping to accelerate drug discovery and precision medicine for the biotech and pharmaceutical industries. Researchers can now more efficiently identify protein structures and interpret genomic data, which improves drug development processes. These tools reduce the time-to-market for life-saving treatments and enhance collaboration among research teams. They also support multi-cloud environments for seamless integration.

Who Are The Companies Driving Activity In The Precision Medicine Market?

Major companies operating in the precision medicine market are Quest Diagnostics, Thermo Fisher Scientific Inc., Roche Holding AG, Medtronic plc, Novartis AG, Pfizer Inc., Qiagen, AstraZeneca plc., Abbott Laboratories, Nordic Bioscience A/S, Takeda Pharmaceutical Company Ltd., Otsuka Pharmaceutical Co. Ltd., Daiichi Sankyo, China National Pharmaceutical Group Co. Ltd., GE Healthcare, Randox Laboratories, Almac Group, Sun Pharma, Nichi-Iko Pharmaceutical Co. Ltd., Daewoong Pharmaceutical Co.Ltd, GlaxoSmithKline, Teva UK Limited, Vectura Group, Merck & Co., Boehringer Ingelheim, Mylan, Zentiva, Sanofi, Apotex, Gilead Sciences, Bayer, AbbVie Inc., Amgen, Janssen Pharmaceutica, Accord Healthcare Inc., Acerus Precision Medicine Corporation, AA Pharma Inc, Sanfer, LABORATORIOS SENOSIAIN SA DE CV, Siegfried Rhein, Biocrates LifeSciences, Nanostring Technologies, Tepnel Pharma Services, Intomics, Silicon Biosystems, EMS Pharma, Eurofarma, Biolab Farmaceutica, Cristalia, União Quimica

Get The Full Precision Medicine Market Report:

https://www.thebusinessresearchcompany.com/report/precision-medicine-global-market-report

Which Geographic Region Dominates The Precision Medicine Market?

North America was the largest region in the precision medicine market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the precision medicine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Precision Medicine Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/precision-medicine-global-market-report

Browse Through More Reports Similar to the Global Precision Medicine Market 2026, By The Business Research Company

Precision Medicine Market Report 2026

https://www.thebusinessresearchcompany.com/report/precision-medicine-global-market-report

Artificial Intelligence Ai In Precision Medicine Market Report 2026

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-precision-medicine-global-market-report

Precision Diagnostics Market Report 2026

https://www.thebusinessresearchcompany.com/report/precision-diagnostics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795